Teleflex Incorporated (NYSE:TFX) Shares Sold by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. lessened its stake in Teleflex Incorporated (NYSE:TFX) by 17.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 54,154 shares of the medical technology company’s stock after selling 11,198 shares during the period. Envestnet Asset Management Inc. owned about 0.12% of Teleflex worth $9,638,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Headlands Technologies LLC purchased a new stake in shares of Teleflex in the 4th quarter valued at $29,000. Avior Wealth Management LLC increased its stake in Teleflex by 81.2% during the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company’s stock worth $50,000 after purchasing an additional 125 shares during the period. IFP Advisors Inc lifted its position in shares of Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock worth $55,000 after purchasing an additional 217 shares in the last quarter. Exchange Traded Concepts LLC boosted its stake in shares of Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after purchasing an additional 94 shares during the period. Finally, R Squared Ltd acquired a new position in shares of Teleflex in the fourth quarter valued at approximately $64,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Analysts Set New Price Targets

TFX has been the topic of a number of research reports. Raymond James lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Citizens Jmp lowered Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Royal Bank of Canada cut Teleflex from an “outperform” rating to a “sector perform” rating and lowered their target price for the stock from $220.00 to $155.00 in a research note on Friday, February 28th. Truist Financial decreased their price objective on Teleflex from $149.00 to $140.00 and set a “hold” rating for the company in a research note on Friday, April 11th. Finally, Morgan Stanley cut their target price on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 5th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $169.63.

Teleflex Stock Performance

Shares of Teleflex stock opened at $129.57 on Friday. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 52 week low of $124.66 and a 52 week high of $249.91. The firm’s 50 day moving average is $143.68 and its two-hundred day moving average is $177.96. The firm has a market capitalization of $6.01 billion, a P/E ratio of 25.76, a P/E/G ratio of 1.73 and a beta of 1.19.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Research analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 1.05%. Teleflex’s dividend payout ratio is presently 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.